Noticias del mercado

Noticias del mercado

Noticias del mercado financiero argentino e internacional — acciones, bonos, CEDEARs, empresas. Actualizadas al instante.

26/02/2026 LLY_US — investor.lilly.com
Lilly's oral GLP-1, orforglipron, delivered superior blood sugar control and weight loss compared to oral semaglutide in head-to-head type 2 diabetes trial published in The Lancet | Eli Lilly and Company

Lilly's oral GLP-1, orforglipron, delivered superior blood sugar control and weight loss compared to oral semaglutide in head-to-head type 2 diabetes trial published in The Lancet | Eli Lilly and…

Página 6344 de 7524

keyboard_arrow_up